Getz K - Search Results

1

Negative symptoms in temporal lobe epilepsy.

Getz K, Hermann B, Seidenberg M, Bell B, Dow C, Jones J, Woodard A, Rutecki P, Sheth R, O'Leary D, Magnotta V. Getz K, et al. Am J Psychiatry. 2002 Apr;159(4):644-51. doi: 10.1176/appi.ajp.159.4.644. Am J Psychiatry. 2002. PMID: 11925304

2

Negative symptoms and psychosocial status in temporal lobe epilepsy.

Getz K, Hermann B, Seidenberg M, Bell B, Dow C, Jones J, Woodard A. Getz K, et al. Epilepsy Res. 2003 Mar;53(3):240-4. doi: 10.1016/s0920-1211(03)00033-0. Epilepsy Res. 2003. PMID: 12694933

3

PFAS Levels, Early Life Factors, and Mammographic Breast Density in Premenopausal Women.

Ning YS, Getz KR, Kyeyune JK, Jeon MS, Luo C, Luo J, Toriola AT. Ning YS, et al. Among authors: getz kr. Environ Health Perspect. 2024 Sep;132(9):97008. doi: 10.1289/EHP14065. Epub 2024 Sep 18. Environ Health Perspect. 2024. PMID: 39292675 Free PMC article.

4

The influence of socioeconomic status on individual attitudes and experience with clinical trials.

Kim JY, Florez M, Botto E, Belgrave X, Grace C, Getz K. Kim JY, et al. Among authors: getz k. Commun Med (Lond). 2024 Sep 5;4(1):172. doi: 10.1038/s43856-024-00586-9. Commun Med (Lond). 2024. PMID: 39237734 Free PMC article.

5

Untargeted lipidomics reveals racial differences in lipid species among women.

Pourali G, Li L, Getz KR, Jeon MS, Luo J, Luo C, Toriola AT. Pourali G, et al. Among authors: getz kr. Biomark Res. 2024 Aug 9;12(1):79. doi: 10.1186/s40364-024-00635-4. Biomark Res. 2024. PMID: 39123257 Free PMC article.

6

Assessing the net financial benefits of employing digital endpoints in clinical trials.

DiMasi JA, Dirks A, Smith Z, Valentine S, Goldsack JC, Metcalfe T, Grewal U, Leyens L, Conradi U, Karlin D, Maloney L, Getz KA, Hartog B. DiMasi JA, et al. Among authors: getz ka. Clin Transl Sci. 2024 Aug;17(8):e13902. doi: 10.1111/cts.13902. Clin Transl Sci. 2024. PMID: 39072949 Free PMC article.

7

Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials.

Shoag J, Li Y, Getz KD, Huang YS, Hall M, Naranjo A, Richardson T, Desai AV, Umaretiya PJ, Aziz-Bose R, Kelly CA, Zheng DJ, Newman H, Zahler S, Aplenc R, Bagatell R, Bona K. Shoag J, et al. Among authors: getz kd. Pediatr Blood Cancer. 2024 Oct;71(10):e31192. doi: 10.1002/pbc.31192. Epub 2024 Jul 12. Pediatr Blood Cancer. 2024. PMID: 38997807

8

Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report.

Leger KJ, Absalon MJ, Demissei BG, Smith AM, Gerbing RB, Alonzo TA, Narayan HK, Hirsch BA, Pollard JA, Razzouk BI, Getz KD, Aplenc R, Kolb EA, Ky B, Cooper TM. Leger KJ, et al. Among authors: getz kd. Front Cardiovasc Med. 2024 Jun 14;11:1347547. doi: 10.3389/fcvm.2024.1347547. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38947228 Free PMC article.

9

New Estimates on the Cost of a Delay Day in Drug Development.

Smith ZP, DiMasi JA, Getz KA. Smith ZP, et al. Among authors: getz ka. Ther Innov Regul Sci. 2024 Sep;58(5):855-862. doi: 10.1007/s43441-024-00667-w. Epub 2024 May 21. Ther Innov Regul Sci. 2024. PMID: 38773058

10

Association between oral targeted cancer drug net health benefit, uptake, and spending.

Lau-Min KS, Wu Y, Rochester S, Bekelman JE, Kanter GP, Getz KD. Lau-Min KS, et al. Among authors: getz kd. J Natl Cancer Inst. 2024 Sep 1;116(9):1479-1486. doi: 10.1093/jnci/djae110. J Natl Cancer Inst. 2024. PMID: 38745430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters